| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,362 |
4,109 |
$241K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,025 |
968 |
$79K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
614 |
609 |
$47K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
592 |
583 |
$46K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,037 |
1,996 |
$42K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
1,277 |
1,262 |
$12K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,099 |
1,082 |
$11K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
114 |
113 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
239 |
235 |
$8K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
78 |
75 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
186 |
175 |
$5K |
| 90461 |
|
340 |
336 |
$5K |
| 99173 |
|
255 |
253 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
71 |
68 |
$4K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
38 |
38 |
$3K |
| 96127 |
|
500 |
495 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
150 |
147 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
56 |
55 |
$623.51 |
| 83655 |
|
52 |
52 |
$573.13 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
18 |
17 |
$453.30 |
| 90686 |
|
573 |
571 |
$216.07 |
| 85018 |
|
55 |
55 |
$121.20 |
| 85014 |
|
53 |
53 |
$116.32 |
| 94760 |
|
26 |
26 |
$25.74 |
| 96160 |
|
218 |
218 |
$20.30 |
| 36416 |
|
14 |
14 |
$0.00 |
| 90633 |
|
14 |
14 |
$0.00 |